Ritholtz Wealth Management Boosts Stock Position in Kewaunee Scientific Co. (NASDAQ:KEQU)

Ritholtz Wealth Management boosted its stake in shares of Kewaunee Scientific Co. (NASDAQ:KEQU) by 15.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 12,619 shares of the technology company’s stock after buying an additional 1,706 shares during the period. Ritholtz Wealth Management owned 0.44% of Kewaunee Scientific worth $781,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the stock. JPMorgan Chase & Co. boosted its stake in Kewaunee Scientific by 18,000.0% during the third quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock worth $30,000 after buying an additional 900 shares during the period. Barclays PLC purchased a new position in shares of Kewaunee Scientific during the 3rd quarter worth approximately $121,000. Heron Bay Capital Management acquired a new stake in Kewaunee Scientific in the 2nd quarter valued at approximately $252,000. State Street Corp purchased a new stake in Kewaunee Scientific in the third quarter valued at approximately $266,000. Finally, Geode Capital Management LLC lifted its stake in Kewaunee Scientific by 8.9% during the third quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock worth $792,000 after purchasing an additional 1,941 shares in the last quarter. 32.69% of the stock is currently owned by hedge funds and other institutional investors.

Kewaunee Scientific Trading Up 2.3 %

NASDAQ KEQU opened at $62.00 on Monday. Kewaunee Scientific Co. has a 52 week low of $27.00 and a 52 week high of $67.20. The firm has a 50 day moving average of $50.58 and a two-hundred day moving average of $45.48. The company has a quick ratio of 2.13, a current ratio of 2.64 and a debt-to-equity ratio of 0.45. The stock has a market capitalization of $177.94 million, a PE ratio of 9.83 and a beta of 0.72.

Insider Activity at Kewaunee Scientific

In related news, CEO Thomas David Hull III sold 1,368 shares of Kewaunee Scientific stock in a transaction on Friday, January 10th. The shares were sold at an average price of $60.08, for a total transaction of $82,189.44. Following the transaction, the chief executive officer now owns 41,129 shares in the company, valued at approximately $2,471,030.32. The trade was a 3.22 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, VP Elizabeth D. Phillips sold 1,850 shares of the business’s stock in a transaction dated Tuesday, December 17th. The stock was sold at an average price of $54.17, for a total value of $100,214.50. Following the transaction, the vice president now owns 13,591 shares in the company, valued at approximately $736,224.47. This represents a 11.98 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 11,994 shares of company stock valued at $729,430 over the last three months. 14.20% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded shares of Kewaunee Scientific from a “hold” rating to a “buy” rating in a research note on Wednesday, December 18th.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.